Proof of Usefulness Report

Orikami

Analysis completed on 2/13/2026

+226
Proof of Usefulness Score
Gaining Momentum

Orikami is a legitimate Dutch MedTech company (est. ~2011) developing digital biomarkers (e.g., MS Sherpa) with validated partnerships (Sanofi, Amgen). However, the project submission is of very low quality, containing false claims ('reach: everyone', 'most people have used my product') and inaccurate financial data ('marketcap 2500000'). While the underlying technology and problem-solution fit are strong, the score is heavily penalized by the lack of verifiable evidence in the submission and the false traction claims. The team size is likely ~15-30, not 125.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+162.5
Audience Reach Impact+10.0
Technical Innovation+78.0
Evidence Of Traction+25.0
Market Timing Relevance+60.0
Functional Completeness+2.5
Subtotal+338
Usefulness Multiplierx0.67 (Correction for submission reliability)
Final Score+226

Project Details

Project URL
Description
Orikami is a Dutch MedTech organization specialized in applied data science and development and implementation of digital biomarkers to enable personalized healthcare for people with chronic diseases. With a team of data scientists and researchers we are on a mission to improve 100 million lives before 2030 by access to personalized healthcare. We believe health data is underutilized. We use real world patient data to enable personalized healthcare paths for our clients to improve outcomes, quality of life and affordable healthcare. Therefore we develop digital biomarkers. Digital biomarkers are defined as objective, quantifiable physiological and behavioural data that are collected and measured by means of digital devices such as portables, wearables, implantables or digestibles. The collected data is typically used to monitor, explain, influence and/or predict health-related outcomes. Advanced analytics, machine learning, artificial intelligence: developments in the field of decision-making based on data analysis are moving fast. Data in healthcare matters!

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline